Table 1. Effect of CMFE on Serum Profile in Rat (n = 6) a, b.
Treatment | AST, U/L | ALT, U/L | ALP, U/L | T-Protein, g/dL | Albumin, g/dL |
---|---|---|---|---|---|
Control + olive oil | 58.12 ± 5.52 | 43.86 ± 6.35 | 214.29 ± 4.83 | 7.85 ± 0.15 | 3.65 ± 0.06 |
1 mL/kg CCl 4 | 155.74 ± 4.21c | 197.4 ± 5.05c | 322.63 ± 10.98 c | 5.83 ± 0.23 c | 1.31 ± 0.08 c |
200 mg/kg CMFE + CCl 4 | 101.82 ± 4.69 d | 133.60 ± 5.59 d | 248.97 ± 6.11 d | 7.10 ± 0.11 d | 2.20 ± 0.09 d |
500 mg/kg CMFE + CCl 4 | 115.03 ± 2.96 d | 116.87 ± 5.65 d | 235.23 ± 5.24 d | 7.25 ± 0.14 d | 2.85 ± 0.12 d |
100 mg/kg Silymarin + CCl 4 | 85.22 ± 3.52 d | 72.92 ± 3.25 d | 223.64 ± 5.23 d | 7.91 ± 0.16 d | 3.20 ± 0.09 d |
a Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CCl4, carbon tetrachloride; CMFE, Cornus mas fruits extract.
b Data are presented in Mean ± SE.
c Indicates significance at P < 0.05 probability from control group.
d Indicates significance at P < 0.05 probability from CCl4 group.